Patent · US Active

Multinuclear complexes and their preparation

US11690923B2 · kind B2 · utility

0Cited by
0References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 19, 2021
Grant dateJul 4, 2023
Priority date
Expiry dateJul 19, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F13/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Multinuclear complexes and methods for preparing them are provided. The discrete multinuclear complexes include a one or more transition metals and a radioisotope having the same coordination geometry as the transition metal. A bridging ligand is coordinated to the transition metal and the radioisotope to link the transition metal and the radioisotope and pendent ligands are coordinated to each of the transition metal and the radioisotope to stabilise the complex. The multinuclear complexes may include a radioisotope or radioelement that can be detected by medical equipment and may find use in therapy and/or the diagnosis of disease in patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.